Bile duct hamartoma occurring in association with long-term treatment with danazol

H M Elmadbouh, HM Elmadbouh, M Douglas-Jones
The British journal of clinical practice · 1997 · vol. 51(3) , pp. 179–80 · PMID:9293063 · W2414112298
Case report OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This case report describes a bile duct hamartoma that developed in a patient undergoing long-term danazol treatment, highlighting the need for close monitoring and potential biopsy for diagnosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We report a case of bile duct hamartoma which developed in a patient who had been on long-term danazol treatment. Such patients should be under close follow-up, preferably with periodic ultrasound examination of the liver. If the patient develops a liver mass, because of non-specific clinical features and imaging appearances, biopsy may be the only way to achieve a definitive diagnosis.

My notes (saved in your browser only)

MeSH descriptors

Bile Duct Neoplasms Danazol Estrogen Antagonists Hamartoma Adult Bile Duct Neoplasms Bile Duct Neoplasms Danazol Estrogen Antagonists Female Hamartoma Hamartoma Humans

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-10T11:21:06.845915+00:00
pubmed
last seen: 2026-10-08T22:00:22.376048+00:00
License: CC0 · commercial use OK